Regenerative Medicine and the Feline Patient is a course designed to cover the basics about Stem Cell Therapy in veterinary medicine and how it can be applied to feline medicine. The objectives of this course are to discuss the potential mechanisms of action, efficacy, and safety. Guidelines on how to use stem cell therapy for the treatment of arthritis, chronic renal disease, IBD, and gingivostomatitis as well as case studies and outcome data will be presented.
Speaker Bio
Robert Harman, DVM, MPVM
Dr. Harman founded and is the CEO of Vet-Stem, the first US-based commercial veterinary stem cell company. For 15 years prior to that, he was the CEO of HTI-Bio-Services, a preclinical research company for veterinary and human pharmaceutical development. He has authored more than 500 contract study reports for human and animal health companies throughout the world and for submission to the FDA and USDA in support of the development of new human and animal health products. In his current position, he is the CEO and principal clinical development director of the programs at Vet-Stem to bring stem cell therapy to veterinary medicine. He has been a frequent speaker at stem cell conferences in North America, Central America, Europe and the Middle East. He has authored peer-reviewed publications and book chapters on stem cell therapy in veterinary medicine.
RACE Credits
This program 249-44275 is approved by the AAVSB RACE to offer a total of 1.00 CE Credits (1.00 max) being available to any one veterinarian: and/or 1.00 Veterinary Technician CE Credits (1.00 max). This RACE approval is for the subject matter categorie(s) of: Medical using the delivery method(s) of: Non-Interactive Distance. This approval is valid in jurisdictions which recognize AAVSB RACE; however, participants are responsible for ascertaining each board’s CE requirements.